© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
September 13, 2021
PT0271 improved lung function and reduced the risk of exacerbations in individuals with asthma.
September 09, 2021
A new study explores why individuals who suffer most from the condition have the worse symptoms at night.
September 03, 2021
Study indicates that patients with asthma should continue taking their asthma medications during the COVID-19 pandemic.
September 02, 2021
Inspiratory muscle training was originally devised to be used by athletes and individuals with breathing problems such as chronic obstructive pulmonary disease, asthma, and bronchitis.
August 19, 2021
Severe persistent asthma is the worse type of asthma.
August 12, 2021
Both asthma and chronic obstructive pulmonary disease cause swelling in the airways that makes it difficult to breathe.
July 16, 2021
Include pediatric patients in demonstrations and discussions to improve outcomes.
July 12, 2021
The FDA also granted Breakthrough Therapy Designation to tezepelumab for patients with severe asthma without an eosinophilic phenotype in September 2018.
June 15, 2021
A 300 mg dose is currently available with a prescription.
June 11, 2021
Dupilumab is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) proteins.